ACADIA PHARMACEUTICALS INC (ACAD)       14.63  -0.03 (-0.2%)

14.63  -0.03 (-0.2%)

US0042251084 - Common Stock - After market: 14.63 0 (0%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.17 -0.19 0.0212.05% Q2 2022 -0.21 -0.25 0.0416.87% Q1 2022 -0.33 -0.61 0.2846.18% Q4 2021 -0.27 -0.24 -0.03-11.34% Q3 2021 -0.09 -0.27 0.1866.19% Q2 2021 -0.27 -0.31 0.0413.13% Q1 2021 -0.42 -0.54 0.1222.52% Q4 2020 -0.42 -0.48 0.0612.68%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -1.31 -1.05 -24.72%Q4 2022 -0.25 -0.27 7.25%FY 2023 -0.56 -1.31 57.04%Q1 2023 -0.29 -0.33 12.09%Q2 2023 -0.18 -0.21 15.90%Q3 2023 -0.18 -0.17 -8.26%Q4 2023 -0.19 -0.25 24.24%FY 2024 0.18 -0.56 131.74%FY 2025 0.07 0.18 -63.38%FY 2026 0.02 0.07 -62.65%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 130.714M 141.42M -10.706M-7.57% Q2 2022 134.563M 133.04M 1.523M1.14% Q1 2022 115.468M 124.35M -8.882M-7.14% Q4 2021 130.758M 138.1M -7.342M-5.32% Q3 2021 131.612M 130.31M 1.302M1.00% Q2 2021 115.221M 127.44M -12.219M-9.59% Q1 2021 106.6M 113.87M -7.27M-6.38% Q4 2020 121M 125.67M -4.67M-3.72%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 541.3M 484.145M 11.81%Q4 2022 137.08M 130.758M 4.83%FY 2023 624.18M 541.3M 15.31%Q1 2023 124.13M 115.468M 7.50%Q2 2023 140.73M 134.563M 4.58%Q3 2023 150.68M 130.714M 15.27%Q4 2023 159.63M 137.08M 16.45%FY 2024 768.69M 624.18M 23.15%FY 2025 862.31M 768.69M 12.18%FY 2026 924.5M 862.31M 7.21%